Literature DB >> 20444525

[Current problems in the prevention and treatment of infections in patients with cirrhosis].

Pablo Bellot1, Neftalí Jara Pérez López, Belén Martínez Moreno, José Such.   

Abstract

Infections in patients with cirrhosis are a common complication causing substantial morbidity and mortality. Bacterial translocation plays an important role in the pathogenesis of many infections in cirrhosis. In turn, infections are involved in the pathogenesis of many episodes of decompensated cirrhosis, such as esophageal variceal bleeding, renal insufficiency, the hemodynamic alterations of cirrhosis, and hepatic encephalopathy. Spontaneous bacterial peritonitis is currently the most frequent infection in cirrhosis. Mortality from this entity has recently decreased due to early diagnosis, the use of appropriate antibiotic therapy, and albumin administration. However, infections due to multiresistant microorganisms have recently increased, leading to greater mortality. Primary prophylaxis with quinolones is effective in preventing infections and is associated with lower mortality in a selected population of patients with liver cirrhosis.
Copyright © 2010 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20444525     DOI: 10.1016/j.gastrohep.2010.02.004

Source DB:  PubMed          Journal:  Gastroenterol Hepatol        ISSN: 0210-5705            Impact factor:   2.102


  2 in total

1.  Prevalence of current patterns and predictive trends of multidrug-resistant Salmonella Typhi in Sudan.

Authors:  Ayman A Elshayeb; Abdelazim A Ahmed; Marmar A El Siddig; Adil A El Hussien
Journal:  Ann Clin Microbiol Antimicrob       Date:  2017-11-14       Impact factor: 3.944

2.  A study on the position and etiology of infection in cirrhotic patients: A potential precipitating factor contributing to hepatic encephalopathy.

Authors:  Qiu-Ming Wang; Qing Ji; Zhi-Jun Duan; Ming Zhang; Qing-Yong Chang
Journal:  Exp Ther Med       Date:  2013-06-03       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.